BDBM204868 EA17/MRS5826::US9227979, 23

SMILES Cn1cc2c(n1)nc(NC(=O)Nc1ccc(CC(=O)NCCCCNC(=S)Nc3ccc(c(c3)C([O-])=O)-c3c4ccc(O)cc4oc4cc(=O)ccc34)cc1)n1nc(nc21)-c1ccco1

InChI Key InChIKey=BUBAUPAIHHUCIV-UHFFFAOYSA-M

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 204868   

TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM204868(US9227979, 23 | EA17/MRS5826)
Affinity DataKi:  60.4nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2016
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandPNGBDBM204868(US9227979, 23 | EA17/MRS5826)
Affinity DataKi:  73.6nMAssay Description:Radioligand binding assays at hA1, hA2A, and hA3ARs were performed according to the procedures described in Gao, Z. G., et al., Biochem Pharmacol. 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2016
Entry Details
Go to US Patent